微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 1.59% | -44.98% | 695% | 90/129 | 4.79% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 0.2% | -88.57% | 166.67% | 94/129 | 3.05% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | -0.3% | -140% | -107.04% | 109/129 | 1.68% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 4.26% | -40.17% | 47.4% | 71/129 | 5.06% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 2.89% | -53.83% | 65.14% | 87/129 | 5.79% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 1.75% | -15.46% | 133.33% | 85/129 | 3.8% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 0.75% | 97.37% | -89.47% | 92/129 | 2.29% | 安杰思 | 8.56% | 行业排名> |
| 2022-12-31 | 7.12% | -22.94% | 13.74% | 78/129 | 13.44% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 6.26% | -20.86% | 202.42% | 76/129 | 12.77% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 2.07% | -57.41% | 444.74% | 94/129 | 9.3% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 0.38% | -63.11% | -95.89% | 97/129 | 6.26% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 9.24% | 13.1% | 16.81% | 87/129 | 17.49% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 7.91% | 175.61% | 62.76% | 73/129 | 15.94% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 4.86% | 367.03% | 371.84% | 82/129 | 11.54% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 1.03% | 162.42% | -87.39% | 88/129 | 6.23% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 8.17% | -37.15% | 184.67% | 97/129 | 25.82% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 2.87% | -68.8% | 257.69% | 76/129 | 19.85% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | -1.82% | -142.62% | -10.3% | 106/129 | 15.16% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | -1.65% | -208.55% | -112.69% | 74/129 | 3.4% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 13% | 3.26% | 41.3% | 64/129 | 14.38% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 9.2% | -3.26% | 115.46% | 33/129 | 10.49% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 4.27% | -2.06% | 180.92% | 50/129 | 6.73% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 1.52% | 8.57% | -87.93% | 36/129 | 2.72% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 12.59% | -27.44% | 32.39% | 57/129 | 12.98% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 9.51% | -26.51% | 118.12% | 26/129 | 7.16% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 4.36% | -51.01% | 211.43% | 33/129 | 3.21% | 明德生物 | 14.54% | 行业排名> |
| 2018-03-31 | 1.4% | -67.06% | -91.93% | 36/129 | 2.62% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | 17.35% | -56.13% | 34.08% | 38/129 | 13.82% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | 12.94% | 2% | 45.39% | 13/129 | 9.43% | 大博医疗 | 30.55% | 行业排名> |
| 2017-06-30 | 8.9% | -47.02% | 109.41% | 13/129 | 5.9% | 基蛋生物 | 23.11% | 行业排名> |
| 2017-03-31 | 4.25% | 2% | -89.25% | 5/129 | 2.66% | 基蛋生物 | 11.34% | 行业排名> |
| 2016-12-31 | 39.55% | 4.8% | 4.8% | 6/129 | 16.21% | 奥泰生物 | 76.87% | 行业排名> |
| 2015-12-31 | 37.74% | 24.68% | 124.64% | 6/129 | 15.95% | 安图生物 | 28% | 行业排名> |
| 2015-06-30 | 16.8% | 2% | -44.5% | 6/129 | 7.77% | 明德生物 | 23.29% | 行业排名> |